Clinical Trial Update: A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing treatments for translocation renal cell carcinoma (tRCC), including metastatic, unresectable, and AJCC Stage III/IV disease; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Renal Cell Carcinoma Unresectable
• Tfe3-rearranged Renal Cell Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-10-10